Capecitabine and oxaliplatin induced Steven –Johnson syndrome following nivolumab in a patient of metastatic esophageal carcinoma

AbstractStevens –Johnson syndrome presents as mucocutaneous blistering and sloughing, which may follow a devastating clinical course. Although Stevens–Johnson syndrome has been reported following the administration of anticancer drugs, only a few cases induced by cytotoxic anticancer drugs, administered after i mmune checkpoint inhibitors, have been reported. The present report describes a case of Stevens–Johnson syndrome caused by capecitabine and oxaliplatin (CAPEOX) combination chemotherapy, in a patient with esophageal squamous cell carcinoma, who had been previously treated with nivolumab.
Source: International Cancer Conference Journal - Category: Cancer & Oncology Source Type: research